BioInvent International AB (publ) (STO:BINV)
Sweden
· Delayed Price · Currency is SEK 29.40
+0.35 (1.20%)
Mar 28, 2025, 1:37 PM CET
STO:BINV Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 44.69 | 71.46 | 326.13 | 19.38 | 147.37 | Upgrade
|
| Revenue Growth (YoY) | -37.47% | -78.09% | 1582.45% | -86.85% | 57.21% | Upgrade
|
| Gross Profit | 44.69 | 71.46 | 326.13 | 19.38 | 147.37 | Upgrade
|
| Selling, General & Admin | 58.3 | 51.61 | 50.75 | 39.44 | 32.16 | Upgrade
|
| Research & Development | 457.73 | 390.43 | 325.93 | 258.34 | 191.42 | Upgrade
|
| Other Operating Expenses | -0.29 | -0.02 | -0.08 | -0.23 | -1.25 | Upgrade
|
| Operating Expenses | 515.75 | 442.02 | 376.6 | 297.55 | 222.33 | Upgrade
|
| Operating Income | -471.06 | -370.56 | -50.47 | -278.17 | -74.96 | Upgrade
|
| Interest Expense | - | -0.64 | -0.65 | -0.52 | -0.34 | Upgrade
|
| Interest & Investment Income | 41.82 | 40.61 | 9.07 | 0.26 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.49 | -0.45 | -0.03 | -1.07 | Upgrade
|
| EBT Excluding Unusual Items | -429.24 | -330.1 | -42.5 | -278.44 | -76.33 | Upgrade
|
| Pretax Income | -429.24 | -330.1 | -42.5 | -278.44 | -76.33 | Upgrade
|
| Income Tax Expense | 0.14 | 0.2 | - | - | - | Upgrade
|
| Net Income | -429.38 | -330.3 | -42.5 | -278.44 | -76.33 | Upgrade
|
| Net Income to Common | -429.38 | -330.3 | -42.5 | -278.44 | -76.33 | Upgrade
|
| Shares Outstanding (Basic) | 66 | 66 | 62 | 54 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 66 | 66 | 62 | 54 | 29 | Upgrade
|
| Shares Change (YoY) | -0.02% | 6.90% | 13.59% | 88.61% | 58.29% | Upgrade
|
| EPS (Basic) | -6.53 | -5.02 | -0.69 | -5.14 | -2.66 | Upgrade
|
| EPS (Diluted) | -6.53 | -5.02 | -0.69 | -5.14 | -2.66 | Upgrade
|
| Free Cash Flow | -390.5 | -355 | -53.6 | -259.1 | -69.32 | Upgrade
|
| Free Cash Flow Per Share | -5.94 | -5.40 | -0.87 | -4.78 | -2.41 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -1054.15% | -518.54% | -15.48% | -1435.02% | -50.86% | Upgrade
|
| Profit Margin | -960.87% | -462.22% | -13.03% | -1436.46% | -51.80% | Upgrade
|
| Free Cash Flow Margin | -873.88% | -496.77% | -16.44% | -1336.68% | -47.04% | Upgrade
|
| EBITDA | -451.76 | -361.29 | -41.91 | -269.79 | -68.86 | Upgrade
|
| EBITDA Margin | - | - | -12.85% | - | -46.72% | Upgrade
|
| D&A For EBITDA | 19.3 | 9.26 | 8.56 | 8.37 | 6.1 | Upgrade
|
| EBIT | -471.06 | -370.56 | -50.47 | -278.17 | -74.96 | Upgrade
|
| EBIT Margin | - | - | -15.48% | - | -50.86% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.